The Series B funding will help advance a study evaluating 'ovarian rebalancing' in women with infertility caused by PCOS.
May Health raises $25m to develop ovarian therapy for women with PCOS
May Health raises $25m to develop ovarian…
May Health raises $25m to develop ovarian therapy for women with PCOS
The Series B funding will help advance a study evaluating 'ovarian rebalancing' in women with infertility caused by PCOS.